We are live on ! Find out more
VRNA

Verona Pharma

Delisted

VRNA was delisted on the 6th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$37.2M
NMC
2
NEA Management Company
Maryland
$33.4M
RCM
3
RA Capital Management
Massachusetts
$33.4M
Wellington Management Group
4
Wellington Management Group
Massachusetts
$25.6M +$788K +113,699 +3%
VC
5
Vivo Capital
California
$19.9M
PA
6
Perceptive Advisors
New York
$18.9M
A
7
Abingworth
United Kingdom
$16M
ACM
8
Aisling Capital Management
New York
$8.71M
FCMI
9
Foresite Capital Management III
California
$7.27M
SB
10
Samsara BioCapital
California
$7.27M
GTC
11
Ghost Tree Capital
New York
$6.54M +$423K +60,957 +6%
SFM
12
Sphera Funds Management
Israel
$5.24M
NHAS
13
Novo Holdings A/S
Denmark
$4.98M -$535K -77,155 -9%
TCM
14
Tekla Capital Management
Massachusetts
$4.92M
BlackRock
15
BlackRock
New York
$1.64M +$1.73M +249,941 New
VP
16
venBio Partners
California
$1.06M
FFM
17
Fairmount Funds Management
Pennsylvania
$549K
SSA
18
Schonfeld Strategic Advisors
New York
$381K +$11.8K +1,700 +3%
DADC
19
D.A. Davidson & Co
Montana
$274K
IWM
20
IHT Wealth Management
Illinois
$121K -$901 -130 -0.7%
WS
21
Wedbush Securities
California
$118K -$27.5K -3,965 -18%
FA
22
Forefront Analytics
Pennsylvania
$104K +$9.73K +1,404 +10%
HSBC Holdings
23
HSBC Holdings
United Kingdom
$101K
QSS
24
Quantitative Systematic Strategies
Florida
$92K -$105K -15,136 -52%
RG
25
Rathbones Group
United Kingdom
$78K